Edgestream Partners, L.P.

Position in PBH — Prestige Consumer Healthcare Inc.

CIK 1535061 Princeton, NJ

Position in PBH

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$323,704

-$6,125,701 QoQ

Shares Held

6,848

-93.7% QoQ

Ownership

0.014%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#193

of 317 holders

Holding Since

Sep 2023

7 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Edgestream Partners, L.P. holds $13,084,437 across 5 Drug Manufacturers - Specialty & Generic names. PBH ranks #5 (2.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	9,178	$4,972,915
2	ZTS	Zoetis Inc.	56,736	$4,077,048
3	SUPN	Supernus Pharmaceuticals, Inc.	66,573	$3,096,310
4	BCRX	Biocryst Pharmaceuticals Inc	61,446	$614,460
5	PBH	Prestige Consumer Healthcare Inc. This page	6,848	$323,704

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$323,704	6,848	-93.7%	Shares	Sole	2026-08-11
2026-03-31	$6,449,405	108,814	-35.4%	Shares	Sole	2026-05-18
2025-12-31	$10,391,125	168,441	+54.5%	Shares	Sole	2026-02-13
2025-09-30	$6,803,097	109,024	-19.5%	Shares	Sole	2025-11-12
2025-06-30	$10,820,553	135,511	+147.5%	Shares	Sole	2025-08-13
2024-09-30	$3,947,258	54,747	+519.4%	Shares	Sole	2024-11-14
2023-09-30	$505,502	8,839	—	Shares	Sole	2023-11-15
No filing history on record for this holder in this stock.